COVID-19 is an emerging, rapidly evolving situation.
COVID-19 public health info from US CDC | COVID-19 research info from the US NIH | COVID-19 resources for global health researchers
Funding news for global health researchers November 23, 2020
On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding
opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates
are typically distributed once a week.
Funding Opportunities
NIH funding opportunities focusing on global health and foreign collaboration.
New funding from the NIH’s National Institute of Mental Health (NIMH): Social Drivers of Mental Illnesses in Low- and Middle-Income Countries: Mechanisms and Pathways of Interventions for Youth
(R01 Clinical Trial Optional) (RFA-MH-21-160)
Application Receipt Date: March 18, 2021
NIH Common Fund's
Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa) program:
Notice of Change: Corrected Application Forms and Extension of Application Due Date for RFA-RM-20-016, Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa) Research Training Program (U2R Clinical Trial Optional) (NOT-RM-21-009)
Updated application due date: December 18, 2020
Notice of Special Interest: Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues
(Admin Supp Clinical Trial Optional) (NOT-OD-21-020)
Fogarty is interested in research and sustainable capacity building activities on ethical issues relevant to low- and middle-income countries, in particular, studies conducted by investigators in these countries.
Application Due Date: March 5, 2021
Reissue: Research Supplements to Promote Diversity in Health-Related Research
(Admin Supp - Clinical Trial Not Allowed) (PA-21-071)
Expiration Date: May 8, 2023
Due dates vary by awarding NIH Institute, Center or Office. Fogarty is participating.
NIH funding opportunities for which foreign organizations, foreign components of U.S. organizations and/or other foreign components may apply.
- NEI Collaborative Clinical Vision Research:
Research: Chair's Grant
(UG1-Clinical Trial Required) (PAR-21-041)
Research Project: Coordinating Center Grant
(UG1 Clinical Trial Required) (PAR-21-042)
Project: Resource Center Grant
(UG1- Clinical Trial Required) (PAR-21-043)
Application Receipt Dates: Standard dates apply - Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders
(U01 Clinical Trial Optional) (PAR-21-058) and
(U44 Clinical Trial Optional) (PAR-21-059)
Application Receipt Dates: February 22, 2021, June 22, 2021, and more
Note: Foreign collaborations that can increase the biomarker utility or uptake are encouraged, but must be clearly justified. - Biological Testing Facility
(X01 Clinical Trial Not Allowed) (PAR-21-078)
Application Receipt Dates: January 15, 2021, July 15, 2021, January 14, 2022, July 15, 2022 - Basic and Clinical Cancer Research:
Innovative Molecular and Cellular Analysis Technologies
(R21 Clinical Trial Not Allowed) (RFA-CA-21-003)
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies
(R33 Clinical Trial Not Allowed) (RFA-CA-21-004)
Innovative Biospecimen Science Technologies
(R21 Clinical Trial Not Allowed) (RFA-CA-21-005)
Advanced Development and Validation of Emerging Biospecimen Science Technologies
(R33 Clinical Trial Not Allowed) (RFA-CA-21-006)
Application Receipt Dates: February 22, 2021; May 27, 2021; September 29, 2021 - Mood and Psychosis Symptoms during the Menopause Transition
(R01 Clinical Trial Optional) (RFA-MH-21-105) and
(R21 Clinical Trial Optional) (RFA-MH-21-106)
Application Receipt Dates: February 9, 2021
Funding News
NIH funding news that may be relevant to global health researchers.
- NIH Implementation of the Revised Federal-wide Research Terms and Conditions (NOT-OD-21-029)
Upcoming Deadlines